Lin Wang, Ruishi Xie, Caijiao Xu, Haoming Luo, Xuefeng Hua, Jiyou Yao, Minqiang Lu, Shuo Zhou, Ming Zhu, Dongyang Li, Xiaoxue Fang
Changchun University of Chinese Medicine, Changchun, China.
School of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Front Immunol. 2025 Apr 30;16:1594224. doi: 10.3389/fimmu.2025.1594224. eCollection 2025.
The mucosal barrier serves as a crucial defense against external pathogens and allergens, being widely distributed across the respiratory, gastrointestinal, urogenital tracts, and oral cavity. Its disruption can lead to various diseases, including inflammatory bowel disease, asthma, urinary tract infections, and oral inflammation. Current mainstream treatments for mucosa-associated diseases primarily involve glucocorticoids and immunosuppressants, but their long-term use may cause adverse effects. Therefore, the development of safer and more effective therapeutic strategies has become a focus of research. Natural products, with their multi-target and multi-system regulatory advantages, offer a promising avenue for the treatment of mucosal diseases. This review summarizes the potential applications of natural products in diseases of mucosal barrier dysfunction through mechanisms such as immune modulation, inflammation inhibition, tight junction protein restoration, and gut microbiota regulation, with the aim of providing insights for the exploration of novel therapeutic strategies.
黏膜屏障作为抵御外部病原体和过敏原的关键防线,广泛分布于呼吸道、胃肠道、泌尿生殖道和口腔。其破坏可导致多种疾病,包括炎症性肠病、哮喘、尿路感染和口腔炎症。目前针对黏膜相关疾病的主流治疗方法主要涉及糖皮质激素和免疫抑制剂,但长期使用可能会产生不良反应。因此,开发更安全、更有效的治疗策略已成为研究的重点。天然产物具有多靶点、多系统调节的优势,为黏膜疾病的治疗提供了一条有前景的途径。本文综述了天然产物通过免疫调节、炎症抑制、紧密连接蛋白恢复和肠道微生物群调节等机制在黏膜屏障功能障碍疾病中的潜在应用,旨在为探索新的治疗策略提供思路。